CA2037300A1 - Derives d'hydroxymacrolides agissant comme immunosuppresseurs - Google Patents

Derives d'hydroxymacrolides agissant comme immunosuppresseurs

Info

Publication number
CA2037300A1
CA2037300A1 CA002037300A CA2037300A CA2037300A1 CA 2037300 A1 CA2037300 A1 CA 2037300A1 CA 002037300 A CA002037300 A CA 002037300A CA 2037300 A CA2037300 A CA 2037300A CA 2037300 A1 CA2037300 A1 CA 2037300A1
Authority
CA
Canada
Prior art keywords
hydrogen
acetyl
ethyl
allyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002037300A
Other languages
English (en)
Inventor
Richard J. Bochis
Hyun O. Ok
Matthew J. Wyvratt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of CA2037300A1 publication Critical patent/CA2037300A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002037300A 1990-03-01 1991-02-28 Derives d'hydroxymacrolides agissant comme immunosuppresseurs Abandoned CA2037300A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/486,700 US5064835A (en) 1990-03-01 1990-03-01 Hydroxymacrolide derivatives having immunosuppressive activity
US486,700 1990-03-01

Publications (1)

Publication Number Publication Date
CA2037300A1 true CA2037300A1 (fr) 1991-09-02

Family

ID=23932923

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002037300A Abandoned CA2037300A1 (fr) 1990-03-01 1991-02-28 Derives d'hydroxymacrolides agissant comme immunosuppresseurs

Country Status (4)

Country Link
US (1) US5064835A (fr)
EP (1) EP0445975A1 (fr)
JP (1) JPH04211690A (fr)
CA (1) CA2037300A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352671A (en) * 1989-11-09 1994-10-04 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
US5208228A (en) * 1989-11-13 1993-05-04 Merck & Co., Inc. Aminomacrolides and derivatives having immunosuppressive activity
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
US5147877A (en) * 1991-04-18 1992-09-15 Merck & Co. Inc. Semi-synthetic immunosuppressive macrolides
US5250678A (en) 1991-05-13 1993-10-05 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5262533A (en) * 1991-05-13 1993-11-16 Merck & Co., Inc. Amino O-aryl macrolides having immunosuppressive activity
US5162334A (en) * 1991-05-13 1992-11-10 Merck & Co., Inc. Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
US5565560A (en) * 1991-05-13 1996-10-15 Merck & Co., Inc. O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5225403A (en) * 1991-06-25 1993-07-06 Merck & Co., Inc. C-21 hydroxylated FK-506 antagonist
US5189042A (en) * 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
US5708002A (en) * 1991-09-05 1998-01-13 Abbott Laboratories Macrocyclic immunomodulators
CA2103454C (fr) * 1991-09-05 2004-11-02 Jay R. Luly Immunomodulateurs macrocycliques
US5247076A (en) * 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5252732A (en) * 1991-09-09 1993-10-12 Merck & Co., Inc. D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5284877A (en) * 1992-06-12 1994-02-08 Merck & Co., Inc. Alkyl and alkenyl macrolides having immunosuppressive activity
US5284840A (en) * 1992-06-12 1994-02-08 Merck & Co., Inc. Alkylidene macrolides having immunosuppressive activity
GB9217116D0 (en) * 1992-08-13 1992-09-23 Smithkline Beecham Corp Methods
US5693648A (en) * 1994-09-30 1997-12-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
US5843936A (en) * 1996-06-28 1998-12-01 Bernstein; Lawrence R. Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
RU2212245C1 (ru) * 2002-03-04 2003-09-20 Нуртдинов Марат Акдасович Способ хирургического лечения сахарного диабета
WO2006115509A2 (fr) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CH677448A5 (fr) * 1987-11-09 1991-05-31 Sandoz Ag
JP2799208B2 (ja) * 1987-12-09 1998-09-17 フアイソンズ・ピーエルシー マクロ環状化合物
EP0358508A3 (fr) * 1988-09-08 1991-03-20 Merck & Co. Inc. Composé immunosuppreseur
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds

Also Published As

Publication number Publication date
EP0445975A1 (fr) 1991-09-11
JPH04211690A (ja) 1992-08-03
US5064835A (en) 1991-11-12

Similar Documents

Publication Publication Date Title
US5064835A (en) Hydroxymacrolide derivatives having immunosuppressive activity
US5143918A (en) Halomacrolides and derivatives having immunosuppressive activity
US5344925A (en) Imidazolidyl macrolides having immunosuppressive activity
US5284840A (en) Alkylidene macrolides having immunosuppressive activity
US5208241A (en) N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5147877A (en) Semi-synthetic immunosuppressive macrolides
US5250678A (en) O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5532248A (en) O-aryl,O-alkyl, and O-alkenyl-macrolides having immunosuppressive activity
US5262533A (en) Amino O-aryl macrolides having immunosuppressive activity
US5208228A (en) Aminomacrolides and derivatives having immunosuppressive activity
US5162334A (en) Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
EP0428365A1 (fr) Amino-macrolides et dérivés ayant une activité immunosuppressive
EP0480623A1 (fr) Halomacrolides et dérivés ayant une activité immunosuppressive
US5563135A (en) Desosamino derivatives of macrolides
EP0463690B1 (fr) Antagonistes des macrolides immunosuppresifs
WO1992020688A1 (fr) Macrolides d'o-aryle, d'o-alkyle, d'o-alcenyle et d'o-alcynyle amino
US5190950A (en) Antagonists of immunosuppressive macrolides
US4920218A (en) Novel hydroxide mediated FK-506 rearrangement process
CA1316916C (fr) Produit du rearrangement du fk-506 par l'entremise d'un hydroxyde
CA2066138A1 (fr) Macrolides immunosuppresseurs semi-synthetiques
US5342935A (en) Antagonists of immunosuppressive macrolides
US4980466A (en) Hydroxide mediated FK-506 rearrangement product
EP0455427A1 (fr) Dérivés de déoxymacrolides à activité immunosuppressive

Legal Events

Date Code Title Description
FZDE Discontinued